Literature DB >> 20953970

Exogenous procalcitonin evokes a pro-inflammatory cytokine response.

Angelike P Liappis1, Kevin W Gibbs, Eric S Nylen, Bona Yoon, Richard H Snider, Baochong Gao, Kenneth L Becker.   

Abstract

OBJECTIVE AND
DESIGN: Procalcitonin (ProCT) is increased in serum of septic patients and those with systemic inflammation. Endogenous levels of ProCT might influence the response of polymorphonuclear leukocytes (PMNs), independently of endotoxin, in clinical disease.
SUBJECTS: Healthy human volunteers. TREATMENT: Recombinant human ProCT (rhProCT).
METHODS: Whole blood and PMNs were exposed in vitro to exogenous rhProCT. Interleukin (IL)-6, IL-8, IL-10, IL-13, tumor necrosis factor-alpha (TNFα), IL-1β, and macrophage inflammatory protein (MIP)-1β (pg/ml) were measured by multiplex suspension bead-array immunoassay, and migration and phagocytosis were measured in PMNs.
RESULTS: In a whole-blood model, a dose-dependent increase in IL-6, TNFα, and IL-1β of the cell-free supernatant was noted. Pre-incubation with ProCT, at doses consistent with clinical sepsis, resulted in a decrease in PMN migration without alteration in phagocytosis of Staphylococcus aureus or indirect measurements of bacterial killing.
CONCLUSION: Clinically relevant levels of ProCT influence immunologic responses that may contribute to systemic inflammatory response and septic shock.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20953970     DOI: 10.1007/s00011-010-0255-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  18 in total

1.  Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis.

Authors:  B Müller; J C White; E S Nylén; R H Snider; K L Becker; J F Habener
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

2.  Migration of human monocytes in response to procalcitonin.

Authors:  Franz J Wiedermann; Nicole Kaneider; Petra Egger; Werner Tiefenthaler; Christian J Wiedermann; Karl H Lindner; Wolfgang Schobersberger
Journal:  Crit Care Med       Date:  2002-05       Impact factor: 7.598

Review 3.  Modulation of PMN-endothelial cells interactions by cyclic nucleotides.

Authors:  Yukio Sato
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

4.  Failure of neutrophil chemotactic function in septic patients.

Authors:  Beatriz M Tavares-Murta; Mateus Zaparoli; Rogério B Ferreira; Mário León Silva-Vergara; Cristina H B Oliveira; Eddie Fernando C Murta; Sérgio H Ferreira; Fernando Q Cunha
Journal:  Crit Care Med       Date:  2002-05       Impact factor: 7.598

5.  Calcitonin gene-related peptide inhibits local acute inflammation and protects mice against lethal endotoxemia.

Authors:  Rachel Novaes Gomes; Hugo C Castro-Faria-Neto; Patricia T Bozza; Milena B P Soares; Charles B Shoemaker; John R David; Marcelo T Bozza
Journal:  Shock       Date:  2005-12       Impact factor: 3.454

6.  Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils.

Authors:  Guillaume Monneret; Maud Arpin; Fabienne Venet; Karim Maghni; Anne-Lise Debard; Alexandre Pachot; Alain Lepape; Jacques Bienvenu
Journal:  Intensive Care Med       Date:  2003-04-24       Impact factor: 17.440

7.  Immunoneutralization of procalcitonin as therapy of sepsis.

Authors:  K L Becker; E S Nylén; R H Snider; B Müller; J C White
Journal:  J Endotoxin Res       Date:  2003

8.  Longitudinal analysis of neutrophil superoxide anion generation in patients with septic shock.

Authors:  M C Vespasiano; J R Lewandoski; J J Zimmerman
Journal:  Crit Care Med       Date:  1993-05       Impact factor: 7.598

9.  Neutrophil chemotaxis and receptor expression in clinical septic shock.

Authors:  Ahmad D Chishti; Brian K Shenton; John A Kirby; Simon V Baudouin
Journal:  Intensive Care Med       Date:  2004-02-28       Impact factor: 17.440

10.  Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.

Authors:  E S Nylen; K T Whang; R H Snider; P M Steinwald; J C White; K L Becker
Journal:  Crit Care Med       Date:  1998-06       Impact factor: 7.598

View more
  19 in total

Review 1.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

Review 2.  Procalcitonin: present and future.

Authors:  H H Liu; J B Guo; Y Geng; L Su
Journal:  Ir J Med Sci       Date:  2015-07-10       Impact factor: 1.568

Review 3.  Overview of procalcitonin in pregnancy and in pre-eclampsia.

Authors:  A Mangogna; C Agostinis; G Ricci; F Romano; R Bulla
Journal:  Clin Exp Immunol       Date:  2019-06-13       Impact factor: 4.330

4.  Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin.

Authors:  Kazuki Murakami; Chiaki Suzuki; Akihiro Fujii; Teruaki Imada
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

5.  Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients.

Authors:  Markéta Marková; Helena Brodská; Karin Malíčková; Veronika Válková; Petr Cetkovský; Michal Kolář; Martin Haluzík
Journal:  Support Care Cancer       Date:  2013-05-28       Impact factor: 3.603

6.  Clinical significance of serum procalcitonin in patients with ulcerative colitis.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Kazuki Takakura; Shunichi Odahara; Shintaro Tsukinaga; Toyokazu Yukawa; Jimi Mitobe; Mikio Kajihara; Kan Uchiyama; Hiroshi Arakawa; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

7.  Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia.

Authors:  Ann C Raddant; Andrew F Russo
Journal:  Headache       Date:  2014-02-11       Impact factor: 5.887

8.  Can serum procalcitonin and C-reactive protein as nosocomial infection markers in hospitalized patients without localizing signs?

Authors:  Farzin Khorvash; Fatemeh Abdi; Kourosh Dialami; Ali Mehrabi Kooshki
Journal:  J Res Med Sci       Date:  2011-10       Impact factor: 1.852

9.  Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells.

Authors:  Giovanni Matera; Angela Quirino; Aida Giancotti; Maria Concetta Pulicari; Linda Rametti; Maria Luz Rodríguez; Maria Carla Liberto; Alfredo Focà
Journal:  BMC Microbiol       Date:  2012-05-08       Impact factor: 3.605

10.  Procalcitonin beyond the acute phase: novel biomediator properties?

Authors:  Carolina Panico; Eric Nylen
Journal:  BMC Med       Date:  2013-08-28       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.